Seegene, Inc.

Seegene, Inc.

Seegene, Inc.

Overview
Date Founded

2000

Headquarters

Taewon Building,91 Ogeum-ro,Songpa-gu,Seoul 05548

Type of Company

Public

Employees (Worldwide)

616

Industries

Medical Products & Equipment
Biotechnology

Company Description

Seegene, Inc. engages in the development, manufacture, and distribution of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Chun on September 16, 2000 and is headquartered in Seoul, South Korea.

Executives & Employees

Chief Executive Officer

Senior Managing Director & Head-Production

Director & Head-Finance

Senior Managing Director

Auditor

Director & Vice President

Board of Directors

Chairman of the Board at Seegene, Inc.

Chief Executive Officer at Seegene, Inc.

Director & Head-Finance at Seegene, Inc.

Director & Vice President at Seegene, Inc.

Independent Director at Seegene, Inc.

Independent Director at Seegene, Inc.

Paths to Seegene, Inc.
Potential Connections via
Relationship Science
You
Seegene, Inc.
Owners & Shareholders
Details Hidden

Hanwha-AM makes long-term investments by analyzing and conducting in-depth research into investment values for their equity management division. They always consider two main factors: growth and value. The firm offers a full range of financial instruments, including stocks, bonds, MMFs, fund of funds, social overhead capital, derivatives, real estate, ETFs, and PEFs in both domestic and overseas capital markets. Hanwha-AM maximizes their efficiency by providing feedback on all their decision-making processes, including in-depth research and state-of-the-art risk management by using the team approach. Their businesses span chemicals & materials, aerospace & mechatronics, solar energy, finance, leisure & lifestyle, and construction.

Details Hidden

KBAM is an active, team-based manager which provides investment management services across all major asset classes and has a wide range of investment products covering various geographic locations. The firm utilizes the Price for Growth process, a systematic decision-making process based on fundamental research capabilities and a matrix system which integrates managing and research functions. They employ long-term purchases (held for at least one year) and frequent trading strategies, selling investments within 30 days of purchase. KBAM overlays their investment management process with a rigorous risk management and compliance system.

Details Hidden

Hanwha-AM makes long-term investments by analyzing and conducting in-depth research into investment values for their equity management division. They always consider two main factors: growth and value. The firm offers a full range of financial instruments, including stocks, bonds, MMFs, fund of funds, social overhead capital, derivatives, real estate, ETFs, and PEFs in both domestic and overseas capital markets. Hanwha-AM maximizes their efficiency by providing feedback on all their decision-making processes, including in-depth research and state-of-the-art risk management by using the team approach. Their businesses span chemicals & materials, aerospace & mechatronics, solar energy, finance, leisure & lifestyle, and construction.

Recent Transactions
Details Hidden

Seegene, Inc. issued KRW Ordinary Shares

Transaction Advisors
Underwriter

Advised onSeegene, Inc. issued KRW Ordinary Shares

Clients

Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health

Key Stats and Financials As of 2020
Market Capitalization
$3.87B
Total Enterprise Value
$4.15B
Earnings Per Share
$8.36
EBITDAMargin
61.64%
Enterprise Value / Sales
4.27x
Enterprise Value EBITDAOperating
6.92x
TEVNet Income
9.56x
Debt TEV
0.02x
Revenue
$973M
Three Year Compounded Annual Growth Rate Of Revenue
134.14%
Total Equity
$559M
Net Profit
$434M
Total Debt
$89.1M
EBITDA
$600M
Suppliers
Bio-Rad Laboratories Inc. Industrial Machinery & Manufacturing | Hercules, CA

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Seegene, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Seegene, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Seegene, Inc..